Unknown OBSERVATIONAL NCT03485690

Time-based Register and Analysis of COPD Endpoints (TRACE)

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Conditions COPD

Updated 9 times since 2018 Last updated: Feb 11, 2020 Started: Jan 1, 2012 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03485690, this observational or N/A phase trial focuses on COPD and remains ongoing. Sponsored by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Recruiting

▶ Show 4 earlier versions

Mar 2020 — Jan 2021 [monthly]

Recruiting
Mar 2019 — Mar 2020 [monthly]

Recruiting
Jun 2018 — Mar 2019 [monthly]

Recruiting
May 2018 — Jun 2018 [monthly]

Recruiting

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Gebro Pharma GmbH

Data source: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seville, Spain